Allelic loss of chromosome 3p24 correlates with tumor progression rather than with retinoic acid receptor β2 expression in breast carcinoma

[1]  M. Miyazaki,et al.  Allelic loss in human intrahepatic cholangiocarcinoma: Correlation between chromosome 8p22 and tumor progression , 2000, International journal of cancer.

[2]  Qifeng Yang,et al.  Active allele loss of the androgen receptor gene contributes to loss of androgen receptor expression in female breast cancers. , 2000, Biochemical and biophysical research communications.

[3]  L. Shan,et al.  Expression of Bcl-2 but not Bax or p53 correlates with in vitro resistance to a series of anticancer drugs in breast carcinoma , 2000, Breast Cancer Research and Treatment.

[4]  S. Lippman,et al.  Lack of correlation between expression of retinoic acid receptor‐beta and loss of heterozygosity on chromosome band 3p24 in esophageal cancer , 2000, Genes, chromosomes & cancer.

[5]  M. Widschwendter,et al.  Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer. , 2000, Journal of the National Cancer Institute.

[6]  S. Sukumar,et al.  Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor β2 promoter in breast cancer cells , 2000, Oncogene.

[7]  K. Kakudo,et al.  Thymidine phosphorylase expression in invasive carcinoma: correlations with clinicopathologic variables and in vitro chemosensitivity to 5-fluorouracil. , 1999, Anticancer research.

[8]  P. Treuting,et al.  Elevated retinoic acid receptor beta(4) protein in human breast tumor cells with nuclear and cytoplasmic localization. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[9]  N. Martinet,et al.  Expression of retinoid receptor genes and proteins in non-small-cell lung cancer. , 1999, Journal of the National Cancer Institute.

[10]  S. Lippman,et al.  Expression and up-regulation of retinoic acid receptor-beta is associated with retinoid sensitivity and colony formation in esophageal cancer cell lines. , 1999, Cancer research.

[11]  Li Yu,et al.  Differential expression of RAB5A in human lung adenocarcinoma cells with different metastasis potential , 1999, Clinical & Experimental Metastasis.

[12]  Y. Nakamura,et al.  Localization of a tumor suppressor gene associated with the progression of human breast carcinoma within a 1‐cm interval of 8p22–p23.1 , 1999, Cancer.

[13]  C. Cooper,et al.  Telomerase repressor sequences on chromosome 3 and induction of permanent growth arrest in human breast cancer cells. , 1999, Journal of the National Cancer Institute.

[14]  A. Mes-Masson,et al.  Mapping of chromosome 3p deletions in human epithelial ovarian tumors , 1998, Oncogene.

[15]  F. Zhan,et al.  A common region of allelic loss on chromosome region 3p25.3–26.3 in nasopharyngeal carcinoma , 1998, Genes, chromosomes & cancer.

[16]  R M Locksley,et al.  Independent and epigenetic regulation of the interleukin-4 alleles in CD4+ T cells. , 1998, Science.

[17]  M. Oshimura,et al.  Repression of the telomerase catalytic subunit by a gene on human chromosome 3 that induces cellular senescence , 1998, Molecular carcinogenesis.

[18]  H. Aburatani,et al.  Loss of heterozygosity of 3p markers in neuroblastoma tumours implicate a tumour-suppressor locus distal to the FHIT gene. , 1998, British Journal of Cancer.

[19]  C Terhorst,et al.  Monoallelic expression of the interleukin-2 locus. , 1998, Science.

[20]  G. Hortobagyi,et al.  Progressive decrease in nuclear retinoic acid receptor beta messenger RNA level during breast carcinogenesis. , 1997, Cancer research.

[21]  V. Seewaldt,et al.  Inhibition of retinoic acid receptor function in normal human mammary epithelial cells results in increased cellular proliferation and inhibits the formation of a polarized epithelium in vitro. , 1997, Experimental cell research.

[22]  M. Widschwendter,et al.  Loss of retinoic acid receptor beta expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer. , 1997, Cancer research.

[23]  Mi-Ock Lee,et al.  Modulation of retinoic acid sensitivity in lung cancer cells through dynamic balance of orphan receptors nur77 and COUP‐TF and their heterodimerization , 1997, The EMBO journal.

[24]  R. Dahiya,et al.  Chromosome 3p24‐26 and 3p22‐12 loss in human prostatic adenocarcinoma , 1997, International journal of cancer.

[25]  A. Thor,et al.  Loss of Heterozygosity in Normal Tissue Adjacent to Breast Carcinomas , 1996, Science.

[26]  R. Kothary,et al.  Lung tumors in mice expressing an antisense RARβ2 transgene , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  A. Read,et al.  Allelic imbalance on chromosome 3p in oral dysplastic lesions: an early event in oral carcinogenesis. , 1996, Cancer research.

[28]  John Calvin Reed,et al.  Retinoic acid receptor beta mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells , 1996, Molecular and cellular biology.

[29]  V. Seewaldt,et al.  Expression of retinoic acid receptor beta mediates retinoic acid-induced growth arrest and apoptosis in breast cancer cells. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[30]  J S Lee,et al.  Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin. , 1995, The New England journal of medicine.

[31]  Cécile Fizames,et al.  The 1993–94 Généthon human genetic linkage map , 1994, Nature Genetics.

[32]  R. Maestro,et al.  Three discrete regions of deletion at 3p in head and neck cancers. , 1993, Cancer research.

[33]  B. Houle,et al.  Tumor-suppressive effect of the retinoic acid receptor beta in human epidermoid lung cancer cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[34]  H. Hausen,et al.  Retinoic acid‐mediated repression of human papillomavirus 18 transcription and different ligand regulation of the retinoic acid receptor beta gene in non‐tumorigenic and tumorigenic HeLa hybrid cells. , 1992, The EMBO journal.

[35]  B. Ljung,et al.  Heterogeneity for allelic loss in human breast cancer. , 1992, Journal of the National Cancer Institute.

[36]  I. Ellis,et al.  Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.

[37]  P. Chambon,et al.  Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines. , 1991, Cancer research.

[38]  A. Gazdar,et al.  Localization of human ERBA2 to the 3p22----3p24.1 region of chromosome 3 and variable deletion in small cell lung cancer. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[39]  L. Sobin,et al.  Histological Typing of Breast Tumors 1 , 1982 .

[40]  Audenino Rg.  [Malignant tumors of the breast]. , 1960, El Dia medico.

[41]  H. Tsou,et al.  Down-Regulation of Retinoic Acid Receptor 3 in Mammary Carcinoma Cell Lines and Its Up-Regulation in Senescing Normal Mammary Epithelial Cells 1 , 2005 .

[42]  Y. Nakamura,et al.  Localization of a breast cancer tumour-suppressor gene to a 3-cM interval within chromosomal region 16q22. , 1997, British Journal of Cancer.

[43]  J. Minna,et al.  Antioncogenes and human cancer. , 1993, Annual review of medicine.

[44]  R. Audenino.  [Malignant tumors of the breast]. , 1960, El Dia medico.